The management of risk and investment in cell therapy process development: a case study for neurodegenerative disease
Cell-based therapies must achieve clinical efficacy and safety with reproducible and cost-effective manufacturing. This study addresses process development issues using the exemplar of a human pluripotent stem cell-based dopaminergic neuron cell therapy product. Early identification and correction o...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Default Article |
| Published: |
2019
|
| Subjects: | |
| Online Access: | https://hdl.handle.net/2134/38131 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|